adme-property-predictor
Predict ADME (Absorption, Distribution, Metabolism, Excretion) properties
Install / Use
npx skills add LeoYeAI/openclaw-master-skills --skill adme-property-predictorInstalls into whichever agent you are using.
SKILL.md
Installable skill definition
Quality Score
Category
Healthcare & Life SciencesSupported Platforms
Tags
Our assessment of adme-property-predictor
adme-property-predictor scores 87/100 on our quality scale, 22nd of 47 Healthcare & Life Sciences skills we index (top 47%).
Its SKILL.md is 23 KB long, well organised into 40 sections with 10 code examples: a thorough specification that gives an agent plenty to work with.
With 2,149 GitHub stars, it is one of the more widely adopted skills in the catalogue.
Maintenance, license and trust
- The repository was last updated about 4 months ago. That is recent enough to be usable, but agent tooling moves fast, so check the instructions against your agent's current version.
- Our last check on 2026-11-02 found the source still online.
- It is released under the MIT license, a permissive license that allows use, modification and commercial use with attribution.
- Its trust signals score 98/100, with no cautions. These come from repository metadata, not a code audit — read the skill file before letting an agent act on it.
Safety scan
No issues foundOur scan of the whole file found no instruction hijacking, hidden characters, credential access, data exfiltration or destructive commands. An AI review of the same text found nothing harmful.
AI review by kimi-k2.7-code on 2026-10-01. Automated pattern scan on 2026-09-30. It catches known dangerous patterns, not every risk — read a skill before letting an agent act on it.
adme-property-predictor compared with similar skills
All 4 of these similar skills score higher than adme-property-predictor; compare them before choosing.
| Skill | Score | Stars | Updated | Format |
|---|---|---|---|---|
| adme-property-predictor (this skill)by LeoYeAI | 87 | 2.1k | 4mo ago | SKILL.md |
| x402by browser-use | 100 | 121.0k | 3d ago | SKILL.md |
| algorithmic-artby anthropics | 100 | 177.9k | 55d ago | SKILL.md |
| pptxby anthropics | 100 | 177.9k | 55d ago | SKILL.md |
| designby nextlevelbuilder | 100 | 149.0k | 6d ago | SKILL.md |
Frequently asked questions
- How do I install adme-property-predictor?
- Run
npx skills add LeoYeAI/openclaw-master-skills --skill adme-property-predictor. The install tabs above show the steps for each supported agent. - Which AI agents does adme-property-predictor work with?
- It is written for Universal, as a SKILL.md file. Other agents that read the same format can often use it too.
- Is adme-property-predictor safe to use?
- Our scan of the whole file found no instruction hijacking, hidden characters, credential access, data exfiltration or destructive commands. An AI review of the same text found nothing harmful. It is MIT-licensed and scores 98/100 on trust signals. Skills are instructions an agent will follow, so read the file before installing it and do not approve commands you do not understand.
- Is adme-property-predictor still maintained?
- The repository was last updated about 4 months ago. That is recent enough to be usable, but agent tooling moves fast, so check the instructions against your agent's current version.
Skill content
View source on GitHubname: adme-property-predictor description: Predict ADME (Absorption, Distribution, Metabolism, Excretion) properties for drug candidates using cheminformatics models and molecular descriptors. Evaluates drug-likeness, bioavailability, and pharmacokinetic profile to guide lead optimization and candidate selection in drug discovery. allowed-tools: [Read, Write, Bash, Edit] license: MIT metadata: skill-author: AIPOCH
ADME Property Predictor
Overview
Comprehensive pharmacokinetic prediction tool that assesses drug-likeness and ADME properties of small molecules using validated cheminformatics models, molecular descriptors, and structure-property relationships.
Key Capabilities:
- Multi-Property Prediction: Absorption, Distribution, Metabolism, Excretion
- Drug-Likeness Scoring: Lipinski's Rule of 5, Veber rules, QED score
- Batch Processing: Analyze compound libraries efficiently
- Structure-Based Insights: Identify liability hotspots and optimization opportunities
- Comparative Analysis: Rank candidates by predicted PK profile
When to Use
✅ Use this skill when:
- Screening compound libraries for drug-like properties in early discovery
- Prioritizing lead compounds for advancement based on predicted PK
- Identifying ADME liabilities requiring structural optimization
- Comparing analogs to select candidates with optimal ADME profiles
- Filtering virtual screening hits before synthesis
- Generating ADME data for regulatory pre-submission packages
- Teaching pharmacokinetics and drug design principles
❌ Do NOT use when:
- Exact PK parameters needed for dosing → Use experimental PK studies
- Biologics (antibodies, proteins) → Use
antibody-pk-predictor - Natural products with complex structures → Models trained on synthetic small molecules
- Prodrugs requiring metabolic activation → Use
prodrug-activation-predictor - Prediction for clinical dosing decisions → CRITICAL: Experimental validation required
- Assessing toxicity or safety → Use
toxicity-structure-alertoradmetox-predictor
Related Skills:
- 上游:
chemical-structure-converter(structure preparation),lipinski-rule-filter(rule-based filtering) - 下游:
drug-candidate-evaluator(integrated scoring),molecular-dynamics-sim(detailed binding)
Integration with Other Skills
Upstream Skills:
chemical-structure-converter: Convert between SMILES, InChI, MOL formatslipinski-rule-filter: Initial rule-based drug-likeness screeningchemical-structure-converter: Generate 3D conformers for structure-based predictionssmiles-de-salter: Remove salt counterions before analysis
Downstream Skills:
drug-candidate-evaluator: Multi-parameter optimization including ADMEtoxicity-structure-alert: Assess safety alongside ADMEtarget-novelty-scorer: Evaluate target uniqueness for selected candidatesbiotech-pitch-deck-narrative: Create investor materials with PK data
Complete Workflow:
Chemical Structure Converter (prepare structures) →
Lipinski Rule Filter (initial filtering) →
ADME Property Predictor (this skill, detailed PK) →
Drug Candidate Evaluator (integrated scoring) →
Toxicity Structure Alert (safety check)
Core Capabilities
1. Absorption (A) Prediction
Predict intestinal absorption, solubility, and permeability:
from scripts.adme_predictor import ADMEPredictor
predictor = ADMEPredictor()
# Predict absorption properties
absorption = predictor.predict_absorption(
smiles="CC(=O)Oc1ccccc1C(=O)O", # Aspirin
properties=["all"] # or specific: ["hia", "caco2", "solubility"]
)
print(absorption.summary())
Predicted Properties: | Property | Model | Units | Interpretation | |----------|-------|-------|----------------| | HIA | ML + physicochemical | % | Human intestinal absorption; >80% good | | Caco-2 | QSPR | 10⁻⁶ cm/s | Permeability; >70 high, <25 low | | Solubility | QSPR | mg/mL | Aqueous solubility; >0.1 mg/mL acceptable | | LogS | QSPR | unitless | Intrinsic solubility; >-4 acceptable | | Lipinski Pass | Rule-based | boolean | Passes all 5 rules | | Veber Pass | Rule-based | boolean | PSA <140, rotatable bonds <10 |
Best Practices:
- ✅ Consider HIA and solubility together (high HIA but low solubility = dissolution-limited)
- ✅ Caco-2 good for oral absorption prediction; poor for BBB penetration
- ✅ Use both rule-based (Lipinski) and ML-based predictions for consensus
- ✅ Check solubility at physiological pH (not just intrinsic)
Common Issues and Solutions:
Issue: Lipinski pass but poor solubility
- Symptom: "Passes Rule of 5 but LogS = -5"
- Solution: Lipinski checks MW and LogP, not solubility directly; use explicit solubility prediction
Issue: Caco-2 predicts high absorption but HIA low
- Symptom: "Caco-2 = 85 (high) but HIA = 60%"
- Solution: Models have different training sets; Caco-2 is in vitro, HIA in vivo; HIA generally more reliable
2. Distribution (D) Prediction
Predict tissue distribution, protein binding, and brain penetration:
# Predict distribution properties
distribution = predictor.predict_distribution(
smiles="CC(=O)Oc1ccccc1C(=O)O",
properties=["vd", "ppb", "bbb"]
)
# Access specific predictions
vd = distribution.volume_of_distribution
bbb = distribution.blood_brain_barrier
ppb = distribution.plasma_protein_binding
Predicted Properties: | Property | Model | Units | Interpretation | |----------|-------|-------|----------------| | Vd | QSPR | L/kg | Volume of distribution; 0.1-10 typical | | PPB | ML | % | Plasma protein binding; >90% high, <50% low | | BBB | LogBB | unitless | Brain penetration; >0.3 penetrant | | fu | Calculated | fraction | Free (unbound) fraction; 1 - PPB/100 |
Best Practices:
- ✅ High PPB (>90%) may require higher doses but longer half-life
- ✅ Low Vd (<0.3) = mainly in plasma; high Vd (>3) = extensive tissue distribution
- ✅ BBB penetration critical for CNS drugs; avoid for peripherally-acting drugs
- ✅ fu (free fraction) drives pharmacological activity, not total concentration
Common Issues and Solutions:
Issue: BBB predictions unreliable for certain chemotypes
- Symptom: "BBB model gives conflicting predictions for peptides"
- Solution: Models trained on small molecules; use specialized BBB predictors for peptides, macrocycles
Issue: PPB overestimated for acidic drugs
- Symptom: "PPB predicted 95% but experimental is 70%"
- Solution: Some models biased toward neutral/basic compounds; check model training set overlap
3. Metabolism (M) Prediction
Predict metabolic stability, CYP interactions, and liability sites:
# Predict metabolism properties
metabolism = predictor.predict_metabolism(
smiles="CC(=O)Oc1ccccc1C(=O)O",
include_site_prediction=True
)
# Check CYP interactions
cyp_profile = metabolism.cyp_profile
stability = metabolism.metabolic_stability
Predicted Properties: | Property | Model | Output | Interpretation | |----------|-------|--------|----------------| | CYP Inhibition | ML | IC50 or class | Potential DDI; <1 μM high risk | | CYP Substrate | Classification | Boolean/Probability | Metabolized by specific CYP | | Stability | ML | T1/2 or class | Microsomal/ hepatocyte stability | | Liability Sites | Reactivity models | Atom indices | Soft spots for metabolism | | MAO Substrate | Classification | Boolean | Monoamine oxidase substrate |
Best Practices:
- ✅ Screen for CYP3A4 inhibition early (most common DDI)
- ✅ Check if compound is CYP substrate (for polymorphism concerns)
- ✅ Identify metabolic hotspots for structural blocking
- ✅ Consider species differences (human vs rodent metabolism)
Common Issues and Solutions:
Issue: False negatives for time-dependent inhibition (TDI)
- Symptom: "No CYP inhibition predicted but TDI observed experimentally"
- Solution: Standard models predict reversible inhibition; use specialized TDI predictors
Issue: Metabolic site prediction shows multiple hotspots
- Symptom: "5 different atoms flagged as metabolic liabilities"
- Solution: Prioritize by reactivity score; consider blocking highest-risk site first
4. Excretion (E) Prediction
Predict clearance routes and elimination kinetics:
# Predict excretion properties
excretion = predictor.predict_excretion(
smiles="CC(=O)Oc1ccccc1C(=O)O",
properties=["clearance", "half_life", "route"]
)
# Access predictions
clearance = excretion.clearance_ml_min_kg
t12 = excretion.half_life_hours
route = excretion.primary_route
Predicted Properties: | Property | Model | Units | Interpretation | |----------|-------|-------|----------------| | CL | QSPR | mL/min/kg | Clearance; <5 low, 5-15 moderate, >15 high | | T1/2 | QSPR | hours | Half-life; 2-8h typical for oral drugs | | Route | Classification | renal/biliary/mixed | Primary excretion pathway | | LogD | QSPR | unitless | Distribution coefficient; affects clearance |
Best Practices:
- ✅ Half-life determines dosing frequency (T1/2 × 5 = time to steady state)
- ✅ Renal clearance predictable for polar compounds; hepatic less predictable
- ✅ High clearance (>15) may require high doses or prodrug approach
- ✅ Very long T1/2 (>24h) good for adherence but risk accumulation
Common Issues and Solutions:
Issue: Clearance predictions highly variable
- Symptom: "Same compound, different models give CL = 5 vs 20 mL/min/kg"
- Solution: Allometry-based methods unreliable for novel scaffolds; use average of multiple models
Issue: Route prediction contradicts structure
- Symptom: "Highly polar compound predicted biliary, expected renal"
- Solution: Check LogP/LogD; polar compounds (<0) usually renal; neutral/lipophilic (>1) usually hepatic
5. Integrated Drug-Likeness Scoring
Overall assessment combining all ADME properties:
# Generate comprehensive drug-likeness score
druglikeness = predictor.calculate_druglikeness(
smiles="CC(=O)Oc1ccccc1C(=O)O",
methods=["qed", "muegge", "golden_triangle"]
)
# Multi-parameter optimization
mpo_score = predictor.mpo_score(
smiles="CC(=O)Oc1ccccc1C(=O)O",
target_profile={"hia": >80, "bbb": <0.3, "t12": "2-8h"}
)
Scoring Methods: | Method | Description | Range | Good Score | |--------|-------------|-------|------------| | QED | Quantitative Estimation of Drug-likeness | 0-1 | >0.6 | | Muegge | Bioavailability score | 0-6 | >4 | | MPO | Multi-Parameter Optimization | 0-10 | >6 |
Best Practices:
- ✅ Use QED as quick overall metric; MPO for property-weighted scoring
- ✅ Don't rely solely on drug-likeness; efficacy and safety equally important
- ✅ Compare to marketed drugs in same class for context
- ✅ Track drug-likeness trends during optimization (should improve)
Common Issues and Solutions:
Issue: Drug-likeness score conflicts with project needs
- Symptom: "CNS drug has low QED (0.5) because high LogP needed for BBB"
- Solution: Drug-likeness rules biased toward oral drugs; use category-specific models (CNS, oncology, etc.)
6. Batch Processing and Library Screening
Analyze compound libraries efficiently:
# Batch process library
results = predictor.batch_predict(
input_file="library.smi", # SMILES file
properties=["all"],
output_format="csv",
n_workers=4 # Parallel processing
)
# Filter by criteria
filtered = results.filter(
lipinski_pass=True,
hia__gt=80,
t12__between=(2, 8)
)
# Rank by multi-parameter score
ranked = results.rank(by="mpo_score", ascending=False)
Best Practices:
- ✅ Process in batches of 1000-10000 for memory efficiency
- ✅ Save intermediate results (crash recovery)
- ✅ Apply filters sequentially (Lipinski first, then detailed ADME)
- ✅ Check property distributions to identify outliers
Common Issues and Solutions:
**Issue: Batch processing ru
Truncated for display — read the full file on GitHub.
Related Skills
x402
121.0kSet up Browser Use Cloud payments with x402 — pay per request from a crypto wallet (USDC on Base mainnet), no signup or API key.
algorithmic-art
177.9kCreating algorithmic art using p5.js with seeded randomness and interactive parameter exploration. Use this when users request creating art using code, generative art, algorithmic art, flow fields, or particle systems.
pptx
177.9kUse this skill any time a .pptx or .potx file is involved in any way — as input, output, or both. This includes: creating slide decks, pitch decks, or presentations; reading, parsing, or extracting text from any .pptx or .potx file (even if the extracted content will be used elsewhere, like in an em…
design
149.0kComprehensive design skill: brand identity, design tokens, UI styling, logo generation (55 styles, Gemini, Atlas Cloud, or MuAPI AI), corporate identity program (50 deliverables, CIP mockups), HTML presentations (Chart.js), banner design (22 styles, social/ads/web/print), icon design (15 styles, SVG…
Languages
Trust signals
From repository metadata: license, adoption, age and documentation. Not a code audit — see the Safety scan above for what the skill file itself contains.
